You searched for "ARN"

391 results found

You can help end avoidable blindness and help people See the Way to a brighter future

Every day, people in the world’s poorest places become needlessly blind because of conditions that can be easily treated.

World leading ophthalmology experts join line-up at free optometry summit in Bristol

Up to 12 CPD points on offer as SpaMedica hosts its 2023 Optometry Conference at The Bristol Pavilion on 26 November.

Unique exhibition conveys experience of visual impairment

The exhibition ‘Windows of the Soul’, part of the Bloomsbury Festival in London, has been pioneered by a combination of young scientists, clinicians and artists, some of whom are visually impaired themselves.

The National Student Ophthalmology Conference 2024

This will be our third annual conference, hosted virtually with the aim to inform and inspire current medical students with interests in ophthalmology. It is a collaborative effort of student representatives from medical schools across the country. - 8 guest...

Cybersight: Clinical Technology & Surgical Techniques in the Evolving Management of Corneal Diseases

The current state of the art in the diagnosis and treatment of corneal diseases depends on imaging techniques to visualize the morphology, 3D structure, and optical quality of the cornea. Improvements in imaging allow for increasingly individualized treatment of corneal...

Phaco nightmares

I am interested in the stressful nature of cataract surgery from the surgeon rather than the patient’s perspective. It is an issue that has quite literally kept me awake at night. Part of getting to grips with a problem is...

Effect of observation of intermittent exotropia on health-related quality of life of children and parents

The authors present the analysis of the Intermittent Exotropia Questionnaire (IXTQ) completed by the observation arm of a previously reported randomised controlled trial comparing part-time patching to observation. Children aged >5 years completed the Child IXTQ, and all parents completed...

Intravitreal ranibizumab for the treatment of myopic CNV

The authors conducted a prospective study. Sixty-four patients (65 eyes) attended the 12-month follow-up examination. The mean patient age was 47.8 years. Fifty-five patients (86.0%) were females. All patients had pathologic myopia (a spherical equivalent of more than − 6.0...

Intravitreal aflibercept for retinal angiomatous proliferation (RAP)

In this prospective study the authors present the visual and anatomical outcome of patients with RAP lesions who were treated with intravitreal aflibercept. The study cohort of 46 patients reached study completion at week 96. They were all Caucasians, with...

RPE tears after intravitreal Lucentis

The current hypothesis regarding retinal pigment epithelium (RPE) tears is the contraction and fibrosis in choroidal neovascularisation (CNV) tissue after anti-VEGF therapy can induce rips in the overlying RPE. This South Korean study aimed to identify the association between RPE...

Intravitreal bevacizumab vs. ranibizumab in the treatment of macular oedema due to BRVO

This is a randomised, prospective, non-inferiority trial of 75 patients with macular oedema due to a branch retinal vein occlusion (BRVO) who received intravitreal injections of ranibizumab or bevacizumab after 1:1 block randomisation. This study is to measure the difference...